LESCH-NYHAN SYNDROME – late diagnosis of rare disease: clinical case
Abstract
Background. Lesch-Nyhan syndrome is inherent X-linked recessive genetic disorder with decreased activity of hypoxanthine-guanine phosphoribosyltransferase (HGPRT). The disease is characterized by presence of the classical triad: hyperuricemia, neurological and behavioral changes. In the article we present a clinical case of Lesch-Nyhan syndrome first diagnosed only at 16 years old despite the fact that the clinical clues were already found at the patient`s early age.
Case presentation. An 18-year-old Caucasian man was admitted to the rheumatology department because of gouty arthritis. In neonatal period he was diagnosed with mild intrauterine growth restriction by hypoplastic type. Uric acid crystals were found in our patient`s urine at 6-month-old. In the first year of life, delayed motor development was noted together with permanent neurological changes which were referred to rickets. During school years, severe dysgraphia, dyslexia, dysarthria, logoneurosis warranted observation by a speech therapist. At his 12 he had been diagnosed with nephrocalcinosis, at 14 – with chronic kidney disease and symptomatic arterial hypertension. The family history was remarkable for gout in grandmother and great-grandmother, chronic pyelonephritis – in mother, urate nephropathy – in both brothers. In physical examination hyperemia and edema of the left first metatarsophalangeal joint, left ankle defiguration, funnel chest, gynecomastia, tophi on the ears were noted. On examination, some neurological disorders and mild cognitive impairment were found. In investigations hyperuricemia, arthritis of the first metatarsophalangeal joint, diffuse changes in the renal parenchyma with impaired renal excretory function were detected. Despite the clues in patient`s anamnesis, objective examination and additional investigation, as well as the presence of a family anamnesis suggesting the hereditary nature of hyperuricemia, the diagnosis of HGPRT deficiency was not made until the age of 16 years.
Conclusion. The presence of Lesch-Nyhan syndrome can be assumed with the progression of muscle tone impairment and movement disorders in a child after the first six months of life in combination with high plasma uric acid concentration and its increased urinary excretion. Difficulties in the syndrome diagnosis are associated not only with a rare occurrence, but with a slight or moderate degree of central nervous system impairment that is often related by doctors to rickets or delivery trauma, as well as low accessibility of molecular genetic testing.
Downloads
References
Yamanaka H. Gout and hyperuricemia in young people. Curr Opin Rheumatol. 2011 Mar; 23 (2): 156–60. https://doi.org/10.1097/BOR.0b013e3283432d35
Kubota M. Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions. J Nutr Metab. 2019; 2019: 3480718. https://doi.org/10.1155/2019/3480718
Tewari N, Mathur V, Sardana D, Bansal K. Lesch-Nyhan syndrome: The saga of metabolic abnormalities and self-injurious behavior. Intractable Rare Dis Res. 2017 Feb; 6 (1): 65–8. https://doi.org/10.5582/irdr.2016.01076
Ceballos-Picot I, Le Dantec A, Brassier A, Jaïs J, Ledroit M, Cahu J, et al. New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients. Orphanet J Rare Dis. 2015 Jan 23; 10: 7. https://doi.org/10.1186/s13023-014-0219-0
Fu R, Ceballos-Picot I, Torres RJ, Larovere LE, Yamada Y, Nguyen KV, et al. Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain. 2014 May; 137 (Pt 5): 1282–303. https://doi.org/10.1093/brain/awt202
Guibinga GH, Barron N, Pandori W. Striatal neurodevelopment is dysregulated in purine metabolism deficiency and impacts DARPP-32, BDNF/TrkB expression and signaling: new insights on the molecular and cellular basis of Lesch-Nyhan Syndrome. PLoS One. 2014; 9 (5): e96575. https://doi.org/10.1371/journal.pone.0096575
Harris JC. Lesch-Nyhan syndrome and its variants: examining the behavioral and neurocognitive phenotype. Curr Opin Psychiatry. 2018 Mar; 31 (2): 96–102. https://doi.org/10.1097/YCO.0000000000000388
Eliseev MS, Barskova VG. Bolezn’ Lesha-Nikhena: klinicheskie proyavleniya i varianty techeniya, analiz sobstvennogo opyta. Modern Rheumatology Journal. 2010; (4): 47–52. https://doi.org/10.14412/1996-7012-2010-620 [in Russian]
Bell S, Kolobova I, Crapper L, Ernst C. Lesch-Nyhan Syndrome: Models, Theories, and Therapies. Mol Syndromol. 2016 Nov; 7 (6): 302–11. https://doi.org/10.1159/000449296
Visser JE, Bär PR, Jinnah HA. Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev. 2000 Apr;32 (2–3): 449–75. https://doi.org/10.1016/s0165-0173(99)00094-6
Doucet BP, Jegatheesan D, Burke J. Late diagnosis of Lesch-Nyhan disease variant. BMJ Case Rep. 2013 Dec 10;2013:bcr2013201997. https://doi.org/10.1136/bcr-2013-201997
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
